APA (7th ed.) Citation

Tokat, Ü. M., Adibi, A., Adibi, A., Aydın, E., Bilgiç, Ş. N., Özgü, E., . . . Demiray, M. Case report: Near-complete response to neratinib-based treatment in HR-positive HER2-amplified metastatic breast cancer refractory to trastuzumab deruxtecan. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Tokat, Ünal Metin, Ashkan Adibi, Ashkan Adibi, Esranur Aydın, Şevval Nur Bilgiç, Eylül Özgü, Onur Tutar, and Mutlu Demiray. Case Report: Near-complete Response to Neratinib-based Treatment in HR-positive HER2-amplified Metastatic Breast Cancer Refractory to Trastuzumab Deruxtecan. Frontiers Media S.A.

MLA (9th ed.) Citation

Tokat, Ünal Metin, et al. Case Report: Near-complete Response to Neratinib-based Treatment in HR-positive HER2-amplified Metastatic Breast Cancer Refractory to Trastuzumab Deruxtecan. Frontiers Media S.A.